查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
快速診斷市場：按產品、按處方、按應用、按最終用戶、按地區 - 規模、份額、展望、機會分析，2023-2030 年
市場調查報告書
商品編碼
1290555

快速診斷市場：按產品、按處方、按應用、按最終用戶、按地區 - 規模、份額、展望、機會分析，2023-2030 年

Rapid Diagnostics Market, By Product, By Prescription, By Application, By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

快速診斷測試是易於使用的測試，通常會在 30 分鐘內提供結果。 它是一種快速現場測試，可在 30 分鐘內完成，快速準確地檢測病原體的存在。 快速的結果使醫療保健專業人員/工作人員能夠做出快速、明智的決策，以挽救當地患者的生命。

市場動態：

傳染病/慢性病患病率不斷上升、COVID-19（大流行）的爆發、護理點診斷的使用不斷增加、政府的積極舉措以及公眾對早期診斷的認識不斷增強這些是預期的關鍵因素在預測期內促進全球快速診斷市場的增長。

例如，2022 年 3 月，Brain Chemistry Labs 和 Arlington Scientific 合作開發了一種易於使用的快速測試套件。 該快速檢測試劑盒可檢測 B-甲氨基-L-丙氨酸 (BMAA) 的存在，這是藍藻藻華中存在的一種毒素，可導致致命的麻痺性疾病肌萎縮側索硬化症 (ALS)。這就是您所做的。

本研究的主要特點

  • 本報告對全球快速診斷市場進行了深入分析，提供了以 2022 年為基準年的預測期（2023-2030 年）的市場規模和復合年增長率。
  • 它還闡明了各個細分市場的潛在收入機會，並概述了該市場有吸引力的投資主張矩陣。
  • 它還提供了有關市場驅動因素、限制因素、機遇、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
  • 它根據以下參數對全球快速診斷市場的主要參與者進行了介紹，包括公司亮點、產品組合、主要亮點、財務業績和戰略。
  • 本研究涵蓋的主要公司包括 Abbott、Danaher、Quidel、BD、LifeScan、Siemens Healthineers、F. Hoffmann-La Roche 和 Ascensia Diabetes Care Holdings 等。
  • 從本報告中獲得的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 本報告面向該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和財務分析師。
  • 利益相關者可以通過用於分析全球快速診斷市場的各種策略矩陣來促進決策。

內容：

第一章調查的目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫

第二章市場展望

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要
  • 連貫的機會地圖 (COM)

第三章市場動態、監管與趨勢分析

  • 市場動態
    • 慢性病/傳染病患病率上升
    • 嚴格的法規和快速診斷的挑戰
    • Covid-19 爆發（全球大流行）
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/批准
  • PEST分析
  • 《PORTER》分析
  • 合併/收購場景

第 4 章全球快速診斷市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 關於 COVID-19 的流行病學
  • 供給側和需求側分析
  • 經濟影響

第 5 章 2017-2030 年全球快速診斷市場（按產品）

  • 消耗品
  • 設備/分析設備

第 6 章全球快速診斷市場（按處方劃分，2017-2030 年）

  • 專業診斷
  • 主頁/OTC 測試

第 7 章按應用劃分的全球快速診斷市場，2017-2030

  • 血糖測試
  • 心血管檢查
  • 傳染病檢測
  • 凝血試驗
  • 血液學檢測
  • 癌症篩查
  • 濫用藥物測試
  • 懷孕/不孕/排卵測試

第 8 章全球快速診斷市場（按最終用戶劃分，2017-2030 年）

  • 醫院和診所
  • 實驗室
  • 個人/家庭護理環境
  • 其他

第 9 章全球快速診斷市場，按地區劃分，2017-2030 年

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第 10 章競爭格局

  • Abbott
  • Danaher
  • Quidel
  • BD
  • LifeScan
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Ascensia Diabetes Care Holdings

第 11 章部分

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5691

Rapid diagnostic tests are easy-to-use tests that provide quick results, usually 30 in minutes or less. These are quick field tests that can be performed in under 30 minutes and detect the presence of a pathogen quickly and accurately. Rapid results enable healthcare professionals/workers to make informed decisions quickly and protect the lives of their patients at the community level.

Market Dynamics:

Rise in prevalence of infectious/chronic diseases, outbreak of COVID-19 (pandemic), rise in usage of point-of-care diagnostics, favorable government initiatives, and rising awareness among people regarding early diagnosis are major factors expected to boost growth of the global rapid diagnostics market during the forecast period.

For instance, in March 2022, Brain Chemistry Labs and Arlington Scientific teamed up to develop an easy-to-use rapid test kit. The rapid test kit will detect the presence of B-methylamino-L-Alanine (BMAA), a toxin present in cyanobacterial blooms, which causes a fatal paralytic disease called Amyotrophic Lateral Sclerosis (ALS).

Key features of the study:

  • This report provides in-depth analysis of the global rapid diagnostics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global rapid diagnostics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbott, Danaher, Quidel, BD, LifeScan, Siemens Healthineers, F. Hoffmann-La Roche, and Ascensia Diabetes Care Holdings, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global rapid diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rapid diagnostics market.

Detailed Segmentation:

  • Global Rapid Diagnostics Market, By Product:
    • Consumables
    • Instruments/Analysers
  • Global Rapid Diagnostics Market, By Prescription:
    • Professional Diagnostics
    • At-Home/OTC-Based Testing
  • Global Rapid Diagnostics Market, By Application:
    • Blood Glucose Testing
    • Cardiometabolic Testing
    • Infectious Disease Testing
    • Blood Coagulation Testing
    • Hematology Testing
    • Cancer Testing
    • Drug of Abuse Testing
    • Pregnancy and Fertility/Ovulation Testing
  • Global Rapid Diagnostics Market, By End User:
    • Hospitals and Clinics
    • Laboratories
    • Individuals/Home Healthcare Settings
    • Others
  • By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Abbott
    • Danaher
    • Quidel
    • BD
    • LifeScan
    • Siemens Healthineers
    • F. Hoffmann-La Roche
    • Ascensia Diabetes Care Holdings

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Prescription
    • Market Snapshot By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in prevalence of chronic/infectious disease
    • Stringent regulations and rapid diagnostics challenges
    • The outbreak of COVID-19 (global pandemic)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Rapid Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Rapid Diagnostics Market, By Product, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Instruments/Analysers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

6. Global Rapid Diagnostics Market, By Prescription, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Professional Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • At-Home/OTC-Based Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

7. Global Rapid Diagnostics Market, By Application, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Blood Glucose Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Cardiometabolic Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Infectious Disease Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Blood Coagulation Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Hematology Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Cancer Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Drug of Abuse Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Pregnancy and Fertility/Ovulation Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

8. Global Rapid Diagnostics Market, By End User, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Individuals/Home Healthcare Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

9. Global Rapid Diagnostics Market, By Geography, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)

10. Competitive Landscape

  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quidel
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BD
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • LifeScan
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ascensia Diabetes Care Holdings
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us